Loading provider…
Loading provider…
Hematology & Oncology Physician in Greenville, SC
NPI: 1346245552Primary Practice Location
ST LUKES HOSPITAL
101 Hospital Dr, Columbus, NC
Primary Employer
Prisma Health University Medical Group
prismahealth.org
HQ Phone
Get MD Joe's Phone NumberMobile
Get MD Joe's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardSC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 199 | 254 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 179 | 280 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 103 | 114 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 45 | 45 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 11 | 13 |
A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours.
Authors: Paul Haluska, Jie Cheng, Lainie Martin, Shannon Westin, Robert Wenham, James Fiorica
Sequential ofatumumab and lenalidomide for the treatment of relapsed and refractory chronic lymphocytic leukemia and small lymphocytic lymphoma.
Authors: Suzanne Fanning, Robert Stuart, Lawrence Afrin
Publication Date: 2014-08-19
Authors: Mark O'Rourke, Edward Chu, Mehmet Copur
Journal: Clin Colorectal Cancer
Publication Date: 2011-04-22
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Abemaciclib, DRUG: Standard Adjuvant ET